Showing results (1671-1680 of 4,014) with videos related to
Sort By:
Pageof 402
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
6-Chloro-3-[5-(3-meth-oxy-8-methyl-4-quinol-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl]-2-methyl-4-phenyl-quinolineHoong-Kun Fun, Chin Sing Yeap, S Sarveswari, et al.Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1,1'-[4-(4-Methoxy-phen-yl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-di-yl]diethanoneM Thenmozhi, T Kavitha, B Palakshi Reddy, et al.Acta Crystallographica. Section E, Structure Reports Online|February 21, 2012
Diisobutyl 4-(3-eth-oxy-4-hy-droxy-phen-yl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxyl-ateHoong-Kun Fun, Madhukar Hemamalini, B Palakshi Reddy, et al.Virology Journal|November 18, 2010
"pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies"Hajib N Madhavan, Moses Y Samson, Murali Ishwarya, et al.Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
1-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl]}piperidin-4-oneTara Shahani, Hoong-Kun Fun, R Venkat Ragavan, et al.Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
(E)-1-(2-Methyl-4-phenyl-quinolin-3-yl)-3-phenyl-prop-2-en-1-oneWan-Sin Loh, Hoong-Kun Fun, R Prasath, et al.Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Dimethyl 4-(3,4-dimethoxy-phen-yl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxyl-ateTara Shahani, Hoong-Kun Fun, B Palakshi Reddy, et al.Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
5-Pentyl-4-phenyl-sulfonyl-1H-pyrazol-3-olTara Shahani, Hoong-Kun Fun, R Venkat Ragavan, et al.Acta Crystallographica. Section E, Structure Reports Online|April 28, 2011
3-Isobutyl-4-phenyl-sulfan-yl-1H-pyrazol-5-olTara Shahani, Hoong-Kun Fun, R Venkat Ragavan, et al.Medical Hypotheses|October 29, 1998
A new look at an old option in the treatment of early-stage prostate cancer: hormone therapy as an alternative to watchful waitingF E Yang, P Y Song, J Wayne, et al.Pageof 402